Literature DB >> 6620137

Steady-state determination of the contribution of lung metabolism to the total body clearance of drugs: application to carbamazepine.

P J Wedlund, S L Chang, R H Levy.   

Abstract

A steady-state approach is proposed to examine the contribution that the lung makes to the total body elimination of medium- to high-clearance drugs. Carbamazepine, a potential candidate of pulmonary metabolism, was investigated by infusion into the femoral vein in seven unrestrained Sprague-Dawley rats (250-300 g). Blood samples (0.45 ml), taken simultaneously from the jugular vein and carotid artery in each rat during the infusion (2-5 days), were assayed in duplicate for carbamazepine by GLC/CI/MS. Venous blood concentrations were used to calculate the total body clearance of carbamazepine, 440 +/- 38 ml/hr (mean +/- SEM), and the difference between simultaneous venous and arterial blood concentrations were used to calculate the extraction ratio of carbamazepine by the lung. The mean extraction ratio of 0.0058 (n = 28) suggests that the lung only contributes approximately 5% to the total body clearance of carbamazepine. It is proposed that this technique could be useful in examining the importance of the lung in the total body clearance of other drugs, and that it has several advantages over some currently used techniques.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620137     DOI: 10.1002/jps.2600720806

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Nipecotic acid: systemic availability and brain delivery after nasal administration of nipecotic acid and n-butyl nipecotate to rats.

Authors:  Hongna Wang; Anwar A Hussain; Peter J Wedlund
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

2.  Inhibition of epoxidation of carbamazepine by valproic acid in the isolated perfused rat liver.

Authors:  S L Chang; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1985-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.